Abstract
HIV protease inhibition has been one of the most effective methods of preventing HIV multiplication in infected organisms. Because of the complementarity that exists between the HIV protease active site and the molecules of substituted fullerenes, these compounds have been used as effective HIV protease inhibitors. In this paper, QSAR models based on experimental half maximum effective concentration (EC50) of substituted fullerenes have been developed. The three descriptors used to build the QSAR models make reference to the properties of the full molecule of the substituted fullerenes or to the properties of fragments of the molecule such as the fullerene core or substituent arms.
Keywords: QSAR, HIV protease inhibition, Substituted fullerenes
Letters in Drug Design & Discovery
Title: The Quantitative Structure Activity Relationships for Predicting HIV Protease Inhibition by Substituted Fullerenes
Volume: 7 Issue: 8
Author(s): Dana Martin and Mati Karelson
Affiliation:
Keywords: QSAR, HIV protease inhibition, Substituted fullerenes
Abstract: HIV protease inhibition has been one of the most effective methods of preventing HIV multiplication in infected organisms. Because of the complementarity that exists between the HIV protease active site and the molecules of substituted fullerenes, these compounds have been used as effective HIV protease inhibitors. In this paper, QSAR models based on experimental half maximum effective concentration (EC50) of substituted fullerenes have been developed. The three descriptors used to build the QSAR models make reference to the properties of the full molecule of the substituted fullerenes or to the properties of fragments of the molecule such as the fullerene core or substituent arms.
Export Options
About this article
Cite this article as:
Martin Dana and Karelson Mati, The Quantitative Structure Activity Relationships for Predicting HIV Protease Inhibition by Substituted Fullerenes, Letters in Drug Design & Discovery 2010; 7 (8) . https://dx.doi.org/10.2174/157018010792062759
DOI https://dx.doi.org/10.2174/157018010792062759 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aptamers: Molecular Tools for Medical Diagnosis
Current Topics in Medicinal Chemistry Phytochemicals to Prevent Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies
Current Neuropharmacology Preface
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Current Pharmaceutical Design Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease
Current Alzheimer Research HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
Current Medicinal Chemistry Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Current Drug Delivery Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
CNS & Neurological Disorders - Drug Targets Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection
Current Drug Metabolism Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety Glutamate Transporter 1: Target for the Treatment of Alcohol Dependence
Current Medicinal Chemistry Brain-metastatic Breast Cancer: Clinical Considerations and Pharmacological Approaches
Anti-Cancer Agents in Medicinal Chemistry Effect of Silver Nanoparticles (AgNPs) on <i>Candida albicans, Candida dubliniensis</i> and <i>Candida guilliermondii</i>
Current Drug Therapy Occurrence of blaTEM and blaROB in Haemophilus species Causing Respiratory Tract Infections
Infectious Disorders - Drug Targets Recent Advances on Neural Tube Defects with Special Reference to Valproic Acid
Endocrine, Metabolic & Immune Disorders - Drug Targets Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets